Form 8-K - Current report:
SEC Accession No. 0001193125-25-143658
Filing Date
2025-06-20
Accepted
2025-06-20 16:15:15
Documents
13
Period of Report
2025-06-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d90779d8k.htm   iXBRL 8-K 27054
2 EX-10.1 d90779dex101.htm EX-10.1 22459
  Complete submission text file 0001193125-25-143658.txt   171055

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iobt-20250619.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20250619_lab.xml EX-101.LAB 17911
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20250619_pre.xml EX-101.PRE 11239
15 EXTRACTED XBRL INSTANCE DOCUMENT d90779d8k_htm.xml XML 3616
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

EIN.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 251061525
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)